Abstract
We have measured the formation of prostacyclin (PGI2) in the rat gastric mucosaex vivo following oral administration of indomethacin, protacine and sodium salicylate (SS). It has been found that protacine, like indomethacin but in contrast to SS, markedly reduces PGI2 synthesis as measured by inhibition of ADP-induced platelet aggregation. Parallel gastro-ulcerogenic studies demonstrate that protacine has very weak gastric irritancy when compared with indomethacin. In addition, the effect of these drugs has been evaluated on thromboxane B2 (TXB2) release by human polymorphonuclears (PMNs) stimulated with A23187 ionophorein vitro. It has been shown that protacine, like indomethacin, strongly inhibits cyclooxygenase activity as measured by radioimmunoassay of TXB2. SS partially prevents the inhibitory effect of either
Similar content being viewed by others
References
T. Corell,Interaction of sodium salicylate and indomethacin in rats as shown by prostacyclin release from gastric mucosa, Prostaglandins20, 63–69 (1979).
P. Conti, M.A. Continenza, M.G. Cifone, E. Alesse, G. Ianni andP.U. Angeletti,Effect of indomethacin or aspirin in association with diflunisal or sodium salicylate on prostacyclin release by rat gastric mucosa, Agents and Actions13, in press (1983).
B.J.R. Whittle,Inhibition of prostacyclin (PGI 2 ) formation in the rat small-intestine and gastric mucosa by the ulcerogen, indomethacin, Br. J. Pharmac.64, 438P (1978).
E. Granström, H. Kindhal andB. Samuelsson,Radioimmunoassay for thromboxane B 2 , Analyt. Lett.9, 611 (1976).
J.L. Humes, C.A. Winter, S.G. Sadowski andF.A. Kuehl,Multiple sites on prostaglandin cyclo-oxygenase are determinants in the action of non-steroidal anti-inflammatory agents, Proc. natn. Acad. Sci. USA78, 2053–2056 (1981).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Conti, P., Cifone, M.G., Alesse, E. et al. A comparative study of the effects of some non-steroidal anti-inflammatory drugs on prostacyclin productionex vivo and on thromboxane B2 release by polymorphonuclearsin vitro . Agents and Actions 15, 91–93 (1984). https://doi.org/10.1007/BF01966982
Issue Date:
DOI: https://doi.org/10.1007/BF01966982